학술논문
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Document Type
Article
Author
Kulkarni, P.S.; Bhamare, C.; Dharmadhikari, A.; Gautam, M.; Poonawalla, C.S.; Shaligram, U.; Kapse, D.; Gunale, B.; Padmapriyadarsini, C.; Thakar, M.; Kurle, S.N.; Gupta, N.; Panda, S.; Bhargava, B.; Vekemans, J.; Bavdekar, A.; Gupta, M.; Kulkarni, P.; Garg, B.S.; Gogtay, N.J.; Tambe, M.; Lalwani, S.; Singh, K.; Munshi, R.; Meshram, S.; Selvavinayagam, T.S.; Pandey, K.; Bhimarasetty, D.M.; Ramakrishnan, S.R.; Budhawant, C.; Bonhomme, C.J.; Kelly, E.J.
Source
In: Human Vaccines and Immunotherapeutics . (Human Vaccines and Immunotherapeutics, 2024, 20(1))
Subject
Language
English
ISSN
2164554X
21645515
21645515